UPDATE: Jefferies Raises PT on Thermo Fisher Scientific from $63 to $64
Jefferies maintained a Buy rating on Thermo Fisher Scientific (NYSE: TMO) and increased its price target from $63 to $64.
Jefferies remarked, “TMO's 2Q12 adj. EPS of $1.22 was $0.06 ahead of consensus on notable core revenue upside that flowed at respectable incremental OP margins (32%; in line); the recast of its Hamilton Lab Workstations unit (pending divestiture) to discontinued ops accounted for $0.02 of the upside. We are raising our 2012 EPS forecast to $4.80 (from $4.75) on the better 2Q12 experience. Our PT moves to $64 (from $63) on higher cash flow forecasts.”
Thermo Fisher Scientific closed at $54.14 on Wednesday.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.